|
1
|
Haddadin KJ, Soutar DS, Oliver RJ, Webster
MH, Robertson AG and MacDonald DG: Improved survival for patients
with clinically T1/T2, N0 tongue tumors undergoing a prophylactic
neck dissection. Head Neck. 21:517–525. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang SF, Kang CJ, Lin CY, Fan KH, Yen TC,
Wang HM, Chen IH, Liao CT, Cheng AJ and Chang JT: Neck treatment of
patients with early stage oral tongue cancer: Comparison between
observation, supraomohyoid dissection, and extended dissection.
Cancer. 112:1066–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lim YC, Lee JS, Koo BS, Kim SH, Kim YH and
Choi EC: Treatment of contralateral N0 neck in early squamous cell
carcinoma of the oral tongue: Elective neck dissection versus
observation. Laryngoscope. 116:461–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim SC, Zhang S, Ishii G, Endoh Y, Kodama
K, Miyamoto S, Hayashi R, Ebihara S, Cho JS and Ochiai A:
Predictive markers for late cervical metastasis in stage I and II
invasive squamous cell carcinoma of the oral tongue. Clin Cancer
Res. 10:166–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ueda G, Sunakawa H, Nakamori K, Shinya T,
Tsuhako W, Tamura Y, Kosugi T, Sato N, Ogi K and Hiratsuka H:
Aberrant expression of beta- and gamma-catenin is an independent
prognostic marker in oral squamous cell carcinoma. Int J Oral
Maxillofac Surg. 35:356–361. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan P, Temam S, El-Naggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosenthal EL, Shreenivas S, Peters GE,
Grizzle WE, Desmond R and Gladson CL: Expression of extracellular
matrix metalloprotease inducer in laryngeal squamous cell
carcinoma. Laryngoscope. 113:1406–1410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanata K, Yamaguchi N, Yoshikawa K, Mezaki
Y, Miura M, Suzuki S, Senoo H and Ishikawa K: Soluble EMMPRIN
(extra-cellular matrix metalloproteinase inducer) stimulates the
migration of HEp-2 human laryngeal carcinoma cells, accompanied by
increased MMP-2 production in fibroblasts. Arch Histol Cytol.
70:267–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sweeny L, Liu Z, Bush BD, Hartman Y, Zhou
T and Rosenthal EL: CD147 and AGR2 expression promote cellular
proliferation and metastasis of head and neck squamous cell
carcinoma. Exp Cell Res. 318:1788–1798. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu T, Zhou M, Peng L, Kong S, Miao R, Shi
Y, Sheng H and Li L: Upregulation of CD147 promotes cell invasion,
epithelial-to-mesenchymal transition and activates MAPK/ERK
signaling pathway in colorectal cancer. Int J Clin Exp Pathol.
7:7432–7441. 2014.PubMed/NCBI
|
|
11
|
Hibino T, Sakaguchi M, Miyamoto S,
Yamamoto M, Motoyama A, Hosoi J, Shimokata T, Ito T, Tsuboi R and
Huh NH: S100A9 is a novel ligand of EMMPRIN that promotes melanoma
metastasis. Cancer Res. 73:172–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi M, Suzuki S and Ishikawa K:
Cyclophilin A-EMMPRIN interaction induces invasion of head and neck
squamous cell carcinoma. Oncol Rep. 27:198–203. 2012.PubMed/NCBI
|
|
13
|
Fang WY, Chen YW, Hsiao JR, Liu CS, Kuo
YZ, Wang YC, Chang KC, Tsai ST, Chang MZ, Lin SH and Wu LW:
Elevated S100A9 expression in tumor stroma functions as an early
recurrence marker for early-stage oral cancer patients through
increased tumor cell invasion, angiogenesis, macrophage recruitment
and interleukin-6 production. Oncotarget. 6:28401–28424. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Markowitz J and Carson WE III: Review of
S100A9 biology and its role in cancer. Biochim Biophys Acta.
1835:100–109. 2013.PubMed/NCBI
|
|
15
|
Suzuki S and Ishikawa K: Combined
inhibition of EMMPRIN and epidermal growth factor receptor prevents
the growth and migration of head and neck squamous cell carcinoma
cells. Int J Oncol. 44:912–917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Erdem NF, Carlson ER, Gerard DA and Ichiki
AT: Characterization of 3 oral squamous cell carcinoma cell lines
with different invasion and/or metastatic potentials. J Oral
Maxillofac Surg. 65:1725–1733. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki S, Sato M, Senoo H and Ishikawa K:
Direct cell-cell interaction enhances pro-MMP-2 production and
activation in co-culture of laryngeal cancer cells and fibroblasts:
Involvement of EMMPRIN and MT1-MMP. Exp Cell Res. 293:259–266.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bordador LC, Li X, Toole B, Chen B, Regezi
J, Zardi L, Hu Y and Ramos DM: Expression of emmprin by oral
squamous cell carcinoma. Int J Cancer. 85:347–352. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koga K, Nabeshima K, Aoki M, Kawakami T,
Hamasaki M, Toole BP, Nakayama J and Iwasaki H: Emmprin in
epithelioid sarcoma: Expression in tumor cell membrane and
stimulation of MMP-2 production in tumor-associated fibroblasts.
Int J Cancer. 120:761–768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LH and Wittekind CH: TNM
Classification of Malignant Tumours. 6th. John Wiley & Sons;
Hoboken, NJ: 2002
|
|
21
|
Asakage T, Yokose T, Mukai K, Tsugane S,
Tsubono Y, Asai M and Ebihara S: Tumor thickness predicts cervical
metastasis in patients with stage I/II carcinoma of the tongue.
Cancer. 82:1443–1448. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koppikar P, Choi SH, Egloff AM, Cai Q,
Suzuki S, Freilino M, Nozawa H, Thomas SM, Gooding WE, Siegfried JM
and Grandis JR: Combined inhibition of c-Src and epidermal growth
factor receptor abrogates growth and invasion of head and neck
squamous cell carcinoma. Clin Cancer Res. 14:4284–4291. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Neri S, Hashimoto H, Kii H, Watanabe H,
Masutomi K, Kuwata T, Date H, Tsuboi M, Goto K, Ochiai A and Ishii
G: Cancer cell invasion driven by extracellular matrix remodeling
is dependent on the properties of cancer-associated fibroblasts. J
Cancer Res Clin Oncol. 142:437–446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Honda K, Ishiyama K, Suzuki S, Oumi E,
Sato T, Kawasaki Y, Saito H and Ishikawa K: Sentinel lymph node
biopsy using computed tomographic lymphography in patients with
early tongue cancer. Acta Otolaryngol. 135:507–512. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sakamoto K, Imanishi Y, Tomita T, Shimoda
M, Kameyama K, Shibata K, Sakai N, Ozawa H, Shigetomi S, Fujii R,
et al: Overexpression of SIP1 and downregulation of E-cadherin
predict delayed neck metastasis in stage I/II oral tongue squamous
cell carcinoma after partial glossectomy. Ann Surg Oncol.
19:612–619. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo H, Li R, Zucker S and Toole BP:
EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis,
also binds interstitial collagenase to the tumor cell surface.
Cancer Res. 60:888–91891. 2000.PubMed/NCBI
|
|
27
|
Nelson AR, Fingleton B, Rothenberg ML and
Matrisian LM: Matrix metalloproteinases: Biologic activity and
clinical implications. J Clin Oncol. 18:1135–1149. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brown PD, Bloxidge RE, Stuart NS, Gatter
KC and Carmichael J: Association between expression of activated
72-kilodalton gelatinase and tumor spread in non-small-cell lung
carcinoma. J Natl Cancer Inst. 85:574–578. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davies B, Waxman J, Wasan H, Abel P,
Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F:
Levels of Matrix Metalloproteases in bladder cancer correlate with
tumor grade and invasion. Cancer Res. 53:5365–5369. 1993.PubMed/NCBI
|
|
30
|
Wu J, Hao ZW, Zhao YX, Yang XM, Tang H,
Zhang X, Song F, Sun XX, Wang B, Nan G, et al: Full-length soluble
CD147 promotes MMP-2 expression and is a potential serological
marker in detection of hepatocellular carcinoma. J Transl Med.
12:1902014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suzuki S, Sato M, Senoo H and Ishikawa K:
Direct cell-cell interaction enhances pro-MMP-2 production and
activation in co-culture of laryngeal cancer cells and fibroblasts:
Involvement of EMMPRIN and MT1-MMP. Exp Cell Res. 293:259–266.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Q, Liu Y, Huang Y, Huang D, Li Y, Wu
J and Duan M: Expression of COX-2, CD44v6 and CD147 and
relationship with invasion and lymph node metastasis in
hypopharyngeal squamous cell carcinoma. PLoS One. 8:e710482013.doi:
10.1371/journal.pone.0071048. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tumuluri V, Thomas GA and Fraser IS: The
relationship of proliferating cell density at the invasive tumour
front with prognostic and risk factors in human oral squamous cell
carcinoma. J Oral Pathol Med. 33:204–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grass GD, Bratoeva M and Toole BP:
Regulation of invadopodia formation and activity by CD147. J Cell
Sci. 125:777–788. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bryne M, Boysen M, Alfsen CG, Abeler VM,
Sudbø J, Nesland JM, Kristensen GB, Piffko J and Bankfalvi A: The
invasive front of carcinomas. The most important area for tumour
prognosis? Anticancer Res. 18:4757–4764. 1998.PubMed/NCBI
|
|
36
|
Sewell DA, Yuan CX and Robertson E:
Proteomic signatures in laryngeal squamous cell carcinoma. ORL J
Otorhinolaryngol Relat Spec. 69:77–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Toda H, Minamiya Y, Kagaya M, Nanjo H,
Akagami Y, Saito H, Ito M, Konno H, Motoyama S and Ogawa J: A novel
immunohistochemical staining method allows ultrarapid detection of
lymph node micrometastases while conserving antibody. Acta
Histochem Cytochem. 44:133–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
